Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma.
about
Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaTargeting the insulin-like growth factor pathway in hepatocellular carcinomaLoss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in miceRapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample poolsEmerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinomaInsulin-like growth factor II in hepatocellular carcinoma.Molecular mechanisms of genomic imprinting and clinical implications for cancer.Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation.Oncogenic role of miR-483-3p at the IGF2/483 locus.Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma.Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factorsThe Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer.
P2860
Q24297344-DA0280B0-51E4-4513-A3AD-4ADB71D3FF75Q26766068-61856828-C844-4537-9D78-B00FCA6AAE83Q27006846-388EDED4-F9FA-4118-AA5B-FDB6C87C93F7Q34474525-E75B8DFC-3F20-40D0-845C-62FD8FE71F0FQ34791385-0AD81E7E-9C31-423A-B40F-D650C7461004Q35988103-D6EE851C-69E4-49B0-863E-F99A55716F7EQ37031704-7F44481A-9796-451F-A373-D9F8CD4F8D74Q37347288-2FB907BE-2251-4D30-9086-F6461186A2B1Q37755101-E26C3C50-D5C1-4E1C-B188-8CC8DBBA173DQ37831991-F488074B-7648-489C-A650-9C2E958D5D2CQ38994050-20A703BD-4D84-4B40-AC96-2C4F99FA8051Q39448358-E3B25164-1EF1-439A-B8AF-56A0DF982B9EQ39715206-C5259A83-426D-4EDB-943A-255B7FD696C2Q40214305-D55451B0-335B-4C7C-AC87-2621606F37FBQ41440845-8B619AD6-6D89-466C-ACE5-C6ABBEC1F9ADQ55483353-4CCDA182-863B-4E33-B1C5-E6C47D278DDF
P2860
Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@en
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@nl
type
label
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@en
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@nl
prefLabel
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@en
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Loss of parental-specific meth ...... uman hepatocellular carcinoma.
@en
P2093
Agnès Marchio
Alain Carrié
Antoine Kerjean
Benoit Terris
Cherif Beljord
Christine Gicquel
Céline Chalas
Dario Sarli
Frédérique Tissier
Jamel Chelly
P2860
P304
P356
10.1002/PATH.1477
P577
2003-11-01T00:00:00Z